ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,815 | -13.0% | 375 | 0.0% | 0.00% | – |
| Q2 2023 | $8,981 | +27.3% | 375 | 0.0% | 0.00% | – |
| Q1 2023 | $7,057 | +18.2% | 375 | 0.0% | 0.00% | – |
| Q4 2022 | $5,970 | -0.5% | 375 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 375 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -44.4% | 375 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | +12.5% | 375 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | +33.3% | 375 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -33.3% | 375 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | 0.0% | 375 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | -55.0% | 375 | 0.0% | 0.00% | – |
| Q4 2020 | $20,000 | +33.3% | 375 | 0.0% | 0.00% | – |
| Q3 2020 | $15,000 | -16.7% | 375 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | +20.0% | 375 | 0.0% | 0.00% | – |
| Q1 2020 | $15,000 | +114.3% | 375 | +100.5% | 0.00% | – |
| Q4 2019 | $7,000 | +16.7% | 187 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | +50.0% | 187 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | – | 187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |